Daiichi Sankyo’s PharmaForce To Invest $145 Million to Expand Sterile Manufacturing Operations
By
PharmaForce, a Columbus, Ohio-based sterile drug product development and manufacturing company, will invest $145 million to expand two of its existing facilities in the area of Columbus, Ohio. The announcement…